{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:30:38Z","timestamp":1786437038536,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["BLW K23AI158813"],"award-info":[{"award-number":["BLW K23AI158813"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.iac.2024.01.001","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T09:50:23Z","timestamp":1707904223000},"page":"281-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Relationship Between Eosinophilic Esophagitis and Immunotherapy"],"prefix":"10.1016","volume":"44","author":[{"given":"Bridget E.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Sacta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wolfset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.iac.2024.01.001_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00535-017-1397-z","article-title":"The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?","volume":"53","author":"Philpott","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"issue":"6","key":"10.1016\/j.iac.2024.01.001_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.anai.2014.08.004","article-title":"Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis","volume":"113","author":"Lucendo","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2024.01.001_bib3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/pai.13458","article-title":"Eosinophilic gastrointestinal disorders and allergen immunotherapy: lights and shadows","volume":"32","author":"Votto","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2024.01.001_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/ACI.0000000000000537","article-title":"Eosinophilic esophagitis during sublingual and oral allergen immunotherapy","volume":"19","author":"Cafone","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2024.01.001_bib5","first-page":"2018","article-title":"Recurrence of eosinophilic oesophagitis with subcutaneous grass pollen immunotherapy","volume":"15","author":"Wells","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.iac.2024.01.001_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.iac.2011.03.003","article-title":"History of immunotherapy: the first 100 years","volume":"31","author":"Fitzhugh","year":"2011","journal-title":"Immunol Allergy Clin North Am"},{"issue":"6","key":"10.1016\/j.iac.2024.01.001_bib7","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.pcl.2015.07.015","article-title":"Current options for the treatment of food allergy","volume":"62","author":"Lanser","year":"2015","journal-title":"Pediatr Clin North Am"},{"issue":"6","key":"10.1016\/j.iac.2024.01.001_bib8","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.jaip.2021.01.045","article-title":"Complete remission of eosinophilic esophagitis with multi-aeroallergen subcutaneous immunotherapy: a case report","volume":"9","author":"Iglesia","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"Suppl 2","key":"10.1016\/j.iac.2024.01.001_bib9","first-page":"S146","article-title":"Allergen specific immunotherapy as a treatment for eosinophilic esophagitis","volume":"5","author":"Perez","year":"2012","journal-title":"World Allergy Organ J"},{"issue":"2","key":"10.1016\/j.iac.2024.01.001_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jaci.2013.04.053","article-title":"Eosinophilic esophagitis treated with immunotherapy to dust mites","volume":"132","author":"Ramirez","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2024.01.001_bib11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.anai.2019.02.022","article-title":"Subcutaneous immunotherapy in patients with eosinophilic esophagitis","volume":"122","author":"Robey","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2024.01.001_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MPG.0000000000003631","article-title":"Oral immunotherapy and risk of eosinophilic esophagitis in children: 15 years' experience","volume":"76","author":"Morales-Cabeza","year":"2023","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.iac.2024.01.001_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.anai.2017.11.016","article-title":"Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy","volume":"120","author":"Petroni","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.iac.2024.01.001_bib14","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1016\/j.jaip.2021.07.048","article-title":"Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy","volume":"9","author":"Nilsson","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.iac.2024.01.001_bib15","doi-asserted-by":"crossref","first-page":"100682","DOI":"10.1016\/j.waojou.2022.100682","article-title":"World allergy organization (WAO) diagnosis and rationale for action against cow's milk allergy (DRACMA) guideline update - XIII - oral immunotherapy for CMA: systematic review","volume":"15","author":"Bognanni","year":"2022","journal-title":"World Allergy Organ J"},{"issue":"3","key":"10.1016\/j.iac.2024.01.001_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.anai.2020.12.007","article-title":"Eosinophilic esophagitis may persist after discontinuation of oral immunotherapy","volume":"126","author":"Hamant","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2024.01.001_bib17","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jaip.2018.01.024","article-title":"Long-term follow-up after baked milk introduction","volume":"6","author":"Dunlop","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"62","key":"10.1016\/j.iac.2024.01.001_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi5586","article-title":"Clonally expanded, GPR15-expressing pathogenic effector T(H)2 cells are associated with eosinophilic esophagitis","volume":"6","author":"Morgan","year":"2021","journal-title":"Sci Immunol"},{"issue":"12","key":"10.1016\/j.iac.2024.01.001_bib19","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1016\/j.jaip.2022.09.028","article-title":"High prevalence of gastrointestinal symptoms and undiagnosed eosinophilic esophagitis among allergic adults","volume":"10","author":"Eid","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2024.01.001_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaip.2017.04.037","article-title":"Eosinophilic esophagitis: latent disease in patients with anaphylactic reaction to cow's milk","volume":"6","author":"Barbosa","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2024.01.001_bib21","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3389\/fimmu.2018.02624","article-title":"Baseline gastrointestinal eosinophilia is common in oral immunotherapy subjects with IgE-mediated peanut allergy","volume":"9","author":"Wright","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.iac.2024.01.001_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaip.2016.11.020","article-title":"The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy","volume":"5","author":"Hill","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.iac.2024.01.001_bib23","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jaip.2018.05.010","article-title":"Eosinophilic esophagitis is a late manifestation of the allergic march","volume":"6","author":"Hill","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2024.01.001_bib24","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.09.053","article-title":"Oral immunotherapy-induced gastrointestinal symptoms and peripheral blood eosinophil responses","volume":"139","author":"Goldberg","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2024.01.001_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaip.2019.07.034","article-title":"Risk factors and treatment outcomes for oral immunotherapy-induced gastrointestinal symptoms and eosinophilic responses (OITIGER)","volume":"8","author":"Goldberg","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2024.01.001_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cgh.2020.05.019","article-title":"Gastrointestinal eosinophil responses in a longitudinal, randomized trial of peanut oral immunotherapy","volume":"19","author":"Wright","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.iac.2024.01.001_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2036.2009.04199.x","article-title":"Correlation between eosinophilic oesophagitis and aeroallergens","volume":"31","author":"Moawad","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.iac.2024.01.001_bib28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0091-6749(03)01715-9","article-title":"Pollen and eosinophilic esophagitis","volume":"112","author":"Fogg","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.iac.2024.01.001_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11882-018-0798-2","article-title":"What is the relationship between eosinophilic esophagitis (EoE) and aeroallergens? Implications for allergen immunotherapy","volume":"18","author":"Egan","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"issue":"11","key":"10.1016\/j.iac.2024.01.001_bib30","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1365-2222.2005.02351.x","article-title":"Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season","volume":"35","author":"Onbasi","year":"2005","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.iac.2024.01.001_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.anai.2015.07.004","article-title":"Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis","volume":"115","author":"Ram","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2024.01.001_bib32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaci.2012.10.057","article-title":"Eosinophilic gastrointestinal disease suggestive of pathogenesis-related class 10 (PR-10) protein allergy resolved after immunotherapy","volume":"131","author":"De Swert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2024.01.001_bib33","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1016\/j.jaip.2021.07.017","article-title":"Management of eosinophilic esophagitis during oral immunotherapy","volume":"9","author":"Chu","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2024.01.001_bib34","article-title":"Treatment of oral immunotherapy-associated eosinophilic esophagitis","author":"Epstein-Rigbi","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2024.01.001_bib35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jaip.2022.11.015","article-title":"How we manage gastrointestinal symptoms during oral immunotherapy through a shared decision-making process-a practical guide for the community practitioner","volume":"11","author":"Chua","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2024.01.001_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2023.08.012","article-title":"Ethical implications of continuing oral immunotherapy after the development of eosinophilic esophagitis","author":"Wilson","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2024.01.001_bib37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cgh.2019.05.014","article-title":"Efficacy of epicutaneous immunotherapy in children with milk-induced eosinophilic esophagitis","volume":"18","author":"Spergel","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.iac.2024.01.001_bib38","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/all.14659","article-title":"Sustained milk consumption after 2 years post-milk epicutaneous immunotherapy for eosinophilic esophagitis","volume":"76","author":"Spergel","year":"2021","journal-title":"Allergy"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856124000018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856124000018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:51Z","timestamp":1778544051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856124000018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0889856124000018"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2024.01.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Relationship Between Eosinophilic Esophagitis and Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2024.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}